Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12612000856819
Ethics application status
Approved
Date submitted
13/08/2012
Date registered
14/08/2012
Date last updated
14/01/2016
Type of registration
Prospectively registered
Titles & IDs
Public title
Postprandial effects of almond lipids on cardiovascular risk factors
Query!
Scientific title
Postprandial effects of almond lipids on cardiovascular risk factors in healthy male and female subjects
Query!
Secondary ID [1]
281020
0
Nil
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Postprandial effects of almond lipids on cardiovascular risk factors
287155
0
Query!
Condition category
Condition code
Cardiovascular
287474
287474
0
0
Query!
Normal development and function of the cardiovascular system
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
This is a randomised controlled dietary intervention trial, involving healthy (BMI <30kg/m2) human adults. Subjects will receive in random order the following treatments with a washout period of at least one week between the treatments:
1. raw almonds (approx. 60g)
2. almond extract or milk (apprrox. 300mL)
3. almond oil emulsion (approx. 300mL)
4. almond oil (approx. 30g)
At each of the 4 study visits, subjects will donate a blood sample at 0, 1.5, 2.0, 2.5, 3.0, 3.5, 5.0 and 6.0 hours for assessment
Query!
Intervention code [1]
285479
0
Prevention
Query!
Comparator / control treatment
Active (cross-over study). There is no control group as each participant's fasting blood sample will act as the control and compared to blood samples collected following each of the treatments. This will be for each of the 4 interventions.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
287742
0
The aim of this project is to examine the effects of matrix in which almond lipids are complexed on postprandial lipid levels, inflammation markers, and satiety hormones.
The primary outcome measured are the changes in lipids
Query!
Assessment method [1]
287742
0
Query!
Timepoint [1]
287742
0
At each of the 4 intervention sessions, blood will be collected and these biomarkers measured at baseline, 1.5, 2.0, 2.5, 3.0, 3.5, 5.0 and 6.0 hours after treatment.
Query!
Secondary outcome [1]
298759
0
The secondary outcome measured are the changes in inflammatory biomarkers (Human C reactive protein
Tumour necrosis factor-aplha, Interleukin-6)
Query!
Assessment method [1]
298759
0
Query!
Timepoint [1]
298759
0
At each of the 4 intervention sessions, blood will be collected and these biomarkers measured at baseline, 1.5, 2.0, 2.5, 3.0, 3.5, 5.0 and 6.0 hours after treatment.
Query!
Eligibility
Key inclusion criteria
Healthy male or female.
Are aged between 18-65 years at initial assessment.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
65
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
Yes
Query!
Key exclusion criteria
Currently on cholesterol lowering drugs
Currently on non-steroidal anti-inflammatory drugs
Currently on weight loss program
Have a body mass index (BMI) higher than 30
Diagnosed with any gastrointestinal disorder
Diabetes
Pregnancy or lactation
Allergic to nuts, particularly almonds
Query!
Study design
Purpose of the study
Prevention
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Participants will be recruited from the community using media advertising. Potential participants will contact the study investigator and be given a copy of the Information Statement for the study to consider their participation and consent. Participants will be screened for eligility by the researcher either in person or over the phone using the inclusion and exclusion criteria as mentioned previously. Elibigle participants would then be allocated a number using central randomisation by computer.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Participants will be assigned to a participant identifcation number (PIN) once enrolled. The numbers will have already been assigned to a treatment group which determines the treatment allocation of the participant.
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Bio-availability
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
30/08/2012
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
20
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Funding & Sponsors
Funding source category [1]
285807
0
Self funded/Unfunded
Query!
Name [1]
285807
0
Nutraceuticals Research
Query!
Address [1]
285807
0
Univerisity of Newcastle,
University Drive,
Callaghan, NSW 2308
Query!
Country [1]
285807
0
Australia
Query!
Primary sponsor type
Other Collaborative groups
Query!
Name
Riddet Institute
Query!
Address
Cnr University Avenue and Orchard Road,
Massey University
Palmerston North 4442
Query!
Country
New Zealand
Query!
Secondary sponsor category [1]
284631
0
University
Query!
Name [1]
284631
0
University of Newcastle
Query!
Address [1]
284631
0
University of Newcastle,
University Drive, Callaghan
NSW 2308
Query!
Country [1]
284631
0
Australia
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
287822
0
Human Research Ethics Committee of The University of Newcastle
Query!
Ethics committee address [1]
287822
0
The Chancellory Building
The University of Newcastle,
University Drive
Callaghan, NSW 2308
Query!
Ethics committee country [1]
287822
0
Australia
Query!
Date submitted for ethics approval [1]
287822
0
01/02/2012
Query!
Approval date [1]
287822
0
29/05/2012
Query!
Ethics approval number [1]
287822
0
H-2012-0119
Query!
Summary
Brief summary
Although the association of nutritional composition of foods with health parameters is well established, the physical structure can influence the digestion, absorption and consequently may affect caridovascular health indices namely, circulating lipid levels, inflammatory mediators and satiety hormones. Interactions between the nutrients due to food processing can change, influencing the accessibility of the digestive enzymes for hydrolysis. In this context, although type of dietary fat consumed has been shown to modulate blood cholesterol levels, the matrix of the food may influence its cholesterol raising/lowering potential. Accordingly, the rate of absorption of fat from a meal containing whole almonds has been shown to be much slower compared to almond oil.
The aim of this project is to examine the effects of matrix in which almond lipids are complexed on postprandial lipid levels, inflammation markers, and satiety hormones. This will be achieved by determining the effects of feeding four different almond preparations, i.e. lipids trapped within the cell walls (raw almonds), oleosin-stabilized lipid emulsion (almond extract or milk), casein-stabilized lipid emulsion (almond oil emulsion) and lipids as free oil (almond oil).
We hypothesise that the rate of absorption of fat from almonds, almond oil and emulsified almond oil will be different and in turn may influence cardiovascular disease risk factors.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
34572
0
Query!
Address
34572
0
Query!
Country
34572
0
Query!
Phone
34572
0
Query!
Fax
34572
0
Query!
Email
34572
0
Query!
Contact person for public queries
Name
17819
0
Manohar Garg
Query!
Address
17819
0
305C Medical Sciences Building
The University of Newcastle
Callaghan, NSW 2308
Query!
Country
17819
0
Australia
Query!
Phone
17819
0
+ 61 2 49215647
Query!
Fax
17819
0
+ 612 49212028
Query!
Email
17819
0
[email protected]
Query!
Contact person for scientific queries
Name
8747
0
Manohar Garg
Query!
Address
8747
0
305C Medical Sciences Building
The University of Newcastle
Callaghan, NSW 2308
Query!
Country
8747
0
Australia
Query!
Phone
8747
0
+ 61 2 49215647
Query!
Fax
8747
0
+ 612 49212028
Query!
Email
8747
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF